Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Pavitra Dewda | Clinical Pharmacology | Best Researcher Award

Dr. Pavitra Dewda, GSK – GlaxoSmithKline, Belgium

Dr. Pavitra Dewda is a seasoned Global Medical Director with over a decade of experience in the pharmaceutical and biotechnology industries, specializing in medical strategy, clinical development, and vaccine lifecycle management. Currently at GlaxoSmithKline, she leads global medical strategies for vaccines, focusing on hepatitis, pertussis, and pneumococcal vaccines. Previously, she held leadership roles at Merck KGaA and Sanofi Pasteur, driving initiatives in medical affairs and scientific engagement. Dr. Dewda has been recognized with multiple global awards for her contributions to vaccine education, regulatory affairs, and medical strategy. 🌍💉💊📈👩‍🔬

 

Publication Profile

Scopus

Education & Professional Development

 

Dr. Pavitra Dewda holds an MD from Padmashree Dr. D.Y. Patil University, Pune (2011), and an MBBS from Maharashtra University of Medical Science (2005). Her strong educational foundation in medicine has enabled her to excel in the global pharmaceutical industry. With a passion for medical strategy and vaccine development, Dr. Dewda continues to enhance her expertise through ongoing professional development in clinical affairs, regulatory management, and public health. Her education forms the bedrock for her impactful career in global medical leadership. 🎓💉📚👩‍⚕️

Executive Career Synopsis & Highlights

Dr. Pavitra Dewda is a seasoned global medical leader, currently serving as Global Medical Director at GlaxoSmithKline (GSK) since December 2022. She leads global medical lifecycle accountability for key vaccine portfolios, including hepatitis and pertussis, and drives strategic partnerships, advocacy, and medical strategy. Previously, she was General Manager Medical at GSK India, where she led medical operations, secured regulatory approvals, and executed successful vaccine launches. Dr. Dewda has also held leadership roles at Sanofi and Merck KGaA, excelling in medical affairs, strategic initiatives, and digital transformation, receiving multiple awards for her innovative contributions. 💉🌍🎓

 

Research Focus

Dr. Pavitra Dewda’s research focuses primarily on vaccinology 🦠💉, infectious diseases 🦠, medical affairs 🩺, and fertility medicine 👶. She has contributed to studies on hepatitis A and B vaccination for at-risk adults in Europe, emphasizing healthcare professionals’ knowledge, attitudes, and practices. Dr. Dewda also co-authored research on vaccinating healthcare providers in India, showcasing the importance of immunization in healthcare settings. Additionally, she has explored fertility treatments 🌱, particularly in in vitro fertilization (IVF) outcomes, demonstrating her expertise in both public health and reproductive health. Her work blends clinical research and medical strategy.

 

Publication Top Notes

  • “Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk Adults” – Vaccines, 2023, 11(11), 1645 🦠💉 | Cited by: 1
  • “A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review” – Infectious Diseases and Therapy, 2022, 11(1), 81–99 🩺💉 | Cited by: 5
  • “Association between progesterone elevation on the day of human chronic gonadotropin trigger and pregnancy outcomes after fresh embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cycles” – Frontiers in Endocrinology, 2018, 9(APR), 201 👶⚗️ | Cited by: 23

 

 

Palanisamy Sivanandy | Pharmacology, Toxicology and Pharmaceutical Science | Execellence in Researcher

Posted on by ScienceFather

Dr Palanisamy Sivanandy | Pharmacology, Toxicology and Pharmaceutical Science | Execellence in Researcher

Programme Director at IMU University ,Malaysia

 

Dr. Palanisamy Sivanandy is an accomplished educator and researcher in pharmacy practice with over 17 years of experience in academia. He is currently the Programme Director for the Master in Pharmacy Practice at the International Medical University, Malaysia. With a strong commitment to improving pharmacy education and practice, Dr. Sivanandy has developed and implemented several innovative programs that enhance learning outcomes for pharmacy students. His contributions to the field have been recognized through various awards, including the Teaching Excellence Award and a Fellowship from the Royal Society for Public Health (FRSPH), UK.

Publication profile

ORCID

Education Background

    • Doctor of Philosophy (Ph.D.)
      Specialization: Pharmacy Practice, Pharmaceutical Sciences
      The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India
      2009 – 2012 (Awarded 2013)
    • Master of Pharmacy
      Specialization: Pharmacy Practice
      College of Pharmacy, Sri Ramakrishna Institute of Para-Medical Sciences, Coimbatore, India
      2005 – 2007
    • Bachelor of Pharmacy
      Madurai Medical College, Madurai, India
      2001 – 2005
    • Diploma in Pharmacy
      Royal College of Pharmacy, Coimbatore, India
      1997 – 1999
    • Certifications:
      • Good Clinical Practice (GCP) Certificate, Ministry of Health, Kuala Lumpur, Malaysia (2014)
      • Certificate in Smoking Cessation Organization, Planning and Execution (SCOPE), University of Malaya (2017)
      • Advance Cardiovascular Life Support (ACLS), medtigo Health Education (2021)
      • COVID-19 Training for Healthcare Workers, Stanford Medicine (2021)

Research Interest:

Dr. Sivanandy’s research interests encompass pharmacy practice, pharmaceutical sciences, clinical pharmacy, pharmacovigilance, and evidence-based medicine. He is particularly focused on improving patient care through innovative pharmacy practices and has contributed to several projects on community health and clinical pharmacy education.

Professional Experience

Dr. Palanisamy Sivanandy has over 17 years of teaching experience, with 11 years post-Ph.D. He is currently the Programme Director for the Master in Pharmacy Practice Programme at the International Medical University (IMU) in Kuala Lumpur, Malaysia, where he has served since August 2021. He has held various academic roles at IMU, including Senior Lecturer and Lecturer in the Department of Pharmacy Practice, teaching courses in health care ethics, evidence-based pharmacotherapy, and complementary and alternative medicine.

Prior to his tenure at IMU, Dr. Sivanandy was an Assistant Professor at KMCH College of Pharmacy in Coimbatore, India (2014-2021), where he taught clinical pharmacy, pharmacotherapeutics, and hospital pharmacy. He began his academic career as a Lecturer at Grace College of Pharmacy (2007-2008) and has since contributed significantly to pharmacy education in both India and Malaysia.

Author Metrics:

  • Publications: Over 25 peer-reviewed articles in international journals.
  • Citations: [Insert citation metrics if available]
  • Conference Presentations: Numerous presentations at national and international pharmacy and healthcare conferences.

Publication top notes

Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Posted on by ScienceFather

Dr. Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao, Shandong First Medical University & Shandong Academy of Medical Sciences, China

Dr. Xintian Shao earned her PhD in Microbiology and Biochemical Pharmacy from Shandong University, China, under the guidance of Prof. Peixue Ling. She expanded her expertise as a Visiting Scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Currently serving as an Associate Professor at Shandong First Medical University, her research has yielded 10 impactful publications and secured numerous grants. With two patents to her name, she’s been honored with prestigious awards including the Shandong Medical Science and Technology Award and the Science and Technology Award of Shandong Pharmaceutical Association.

 

Publication Profile 

Scopus

Education and Academic Achievements 📚🏅

Dr. Xintian Shao completed her PhD in Microbiology and Biochemical Pharmacy at the School of Pharmacy, Shandong University, China, under the guidance of Prof. Peixue Ling. She further enriched her expertise as a visiting scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Her prolific research has resulted in 10 publications, including notable contributions to journals such as Advanced Drug Delivery Reviews and Advanced Science. With multiple patents and prestigious grants to her credit, she has earned recognition including the Shandong Medical Science and Technology Award (2021) and the Science and Technology Award of Shandong Pharmaceutical Association (2022).

Work Experience 💼

Dr. Xintian Shao has served as an Associate Professor at the School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, China. Her role involves not only teaching and mentorship but also continued research contributions in her field.

Research Focus

Dr. Xintian Shao’s research primarily focuses on subcellular imaging and targeted drug delivery systems. Her work delves into the intricate dynamics of organelle interactions, particularly within mitochondria and lysosomes, employing cutting-edge super-resolution imaging techniques. She explores novel methods for visualizing drug molecules within living organisms, enhancing our understanding of drug distribution and efficacy. With a keen interest in membrane biology and organelle-specific targeting, her contributions shed light on fundamental cellular processes and hold promise for advancements in drug delivery and therapeutics.

Publication Top Notes 

  1. “Single-organelle localization-based super-resolution imaging for subcellular molecules micro-dynamics” by Fang, G. et al., Coordination Chemistry Reviews, 2024.
  2. “Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms” by Sun, T. et al., Acta Pharmaceutica Sinica B, 2024.
  3. “Mitochondrial nucleoid condensates drive peripheral fission through high membrane curvature” by Chen, Q. et al., Cell Reports, 2023.
    Cited by: 1
  4. “Graphene Oxide Nanosheets Induce Mitochondrial Fragmentation by Cutting through Membrane” by Shao, X. et al., ACS Materials Letters, 2023.
    Cited by: 4
  5. “Subcellular visualization: Organelle-specific targeted drug delivery and discovery” by Shao, X. et al., Advanced Drug Delivery Reviews, 2023.
    Cited by: 7
  6. “Recent advances in fluorescent probes of peroxynitrite: Structural, strategies and biological applications” by Sun, J. et al., Theranostics, 2023.
    Cited by: 8
  7. “Single Image Capture of Bioactive Ion Crosstalk within Inter-Organelle Membrane Contacts at Nanometer Resolution” by Fang, G. et al., Small Methods, 2022.
    Cited by: 8
  8. “Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction” by Wang, H. et al., Frontiers in Pharmacology, 2022.
    Cited by: 4
  9. “Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules” by Wei, Y. et al., Chemical Engineering Journal, 2022.
    Cited by: 19
  10. “Prefused lysosomes cluster on autophagosomes regulated by VAMP8” by Chen, Q. et al., Cell Death and Disease, 2021.
    Cited by: 24